The development of novel anti-hyperlipidemic drugs: a tough business gets tougher
Krause, B.R.
Current Opinion in Investigational Drugs 9(9): 945-949
2008
ISSN/ISBN: 1472-4472 PMID: 18729000 Document Number: 620273
Document emailed within 1 workday
Related Documents
Slomski, A.J. 1992: Business gets tougher than ever on doctors Medical Economics 69(12): 38-41; 44-5; 48-49Covey, H. 1986: Keeping eventers sound in California: shoeing a tough horse for a tough sport in a tough environment is a tough job American farriers' journal 12(5): 24-29
Covey, H. 1986: Keeping eventers sound in California: shoeing a tough horse for a tough sport in a tough environment is a tough job American farriers' journal 12(5): 24-29
Johnson, D.E. 1999: Strategists face tough business decisions Health Care Strategic Management 17(7): 2-3
Kinoshita, M. 2002: Anti-hyperlipidemic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 60(5): 968-974
Zhang, J.; Li, H.-F.; Fan, W.; Liu, Z.; Man, S.-L.; Si, S.-Y.; Gao, W.-Y. 2014: Regularity of drugs compatibility of anti-hepatoma traditional Chinese medicine ancient prescriptions and risk evaluation of anti-hepatoma new drug research and development Zhongguo Zhong Yao Za Zhi 39(19): 3870-3875
Lu, X.-f.; Chen, Z.-w. 2010: The development of anti-HIV-1 drugs Yao Xue Xue Bao 45(2): 165-176
Inoue, D. 2015: New anti-osteoporotic drugs under development Nihon Rinsho. Japanese Journal of Clinical Medicine 73(10): 1712-1717
De Micheli, A. 1987: Development of anti-arrhythmic drugs Archivos del Instituto de Cardiologia de Mexico 57(1): 1-8
Mole, K 2002: Street-Level Technocracy in UK Small Business Support: Business Links, Personal Business Advisers, and the Small Business Service Environment and Planning C 20(2): 179-194
Garner, A. 1994: Development of modern anti-ulcer drugs British Journal of Clinical Practice. Suppl 75: 1-5; Discussion: 6-8
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Pei-Gen, X.; Nai-Gong, W. 1991: Can ethnopharmacology contribute to the development of anti-fertility drugs? Journal of Ethnopharmacology 32(1-3): 167-177
Sato, T.; Nakajima, T.; Yamano, Y. 2010: Development of anti-inflammatory drugs targeted against prostaglandin-related molecules Nihon Rinsho. Japanese Journal of Clinical Medicine 68(10): 1835-1839
Myers, R.L.; Runion, H.I.; O'Brien, D.E. 1979: Development of a microprocessor based screening technique for anti-inflammatory drugs Proceedings of the Western Pharmacology Society 22: 67-71
Dai, X.-m.; An, N.; Wu, J.-m.; Li, H.-y.; Zhang, Q.-m. 2010: Development and validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products Yao Xue Xue Bao 45(3): 347-352
McAnea, C. 2011: Striking is tough--but not as tough as retiring on benefits Nursing Times 107(38): 9
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Williamson, L. 2014: Counterfeit drugs are everyone's business KRANKENPFLEGE. Soins Infirmiers 107(8): 22-23